ReviewDigital health
Virtual communities for patients with lung cancer: A scoping review of support types, effectiveness, and emerging challenges.
Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This review examines how virtual communities support patients with lung cancer, focusing on their effectiveness in improving emotional wellbeing and treatment adherence, and addressing challenges like misinformation and privacy. Methods: A scoping review was conducted using PubMed, CNKI, and Web of Science. Inclusion criteria included patients with lung cancer aged ≥18, virtual community interventions, and original research in Chinese or English. Studies were screened and appraised independently. Results: Nineteen studies (2015-2024) showed that apps and websites were key platforms, offering information, emotional support, and social interaction. These communities reduced anxiety, improved treatment compliance, but did not affect survival rates. Misinformation and privacy were concerns. Conclusions: Virtual communities significantly benefit patients with lung cancer psychologically and socially, but not in survival. Future research should address diversity, longitudinal designs, and platform optimization to reduce risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.